ZTS - Zoetis Inc

NYSE * Health Care * Pharmaceuticals

$131.10

+$1.34 (+1.03%)

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

ZTS Key Statistics

Market Cap

$57.77B

P/E Ratio

21.78

P/B Ratio

16.44

EPS

$6.02

Dividend Yield

0.02%

Revenue Growth

+0.0%

Profit Margin

0.3%

Employees

14,500

How ZTS Compares to Peers

ZTS has the lowest P/E ratio in Pharmaceuticals, suggesting it may be the most undervalued
ZTS has the highest profit margins in Pharmaceuticals
ZTS is the smallest among peers, which may offer higher growth potential

P/E Rank

#1

of 2

Margin Rank

#1

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
ZTS21.80%-
AMZN29.00%vs AMZN

Zoetis Inc Company Information

Headquarters
New Jersey; U.S.A
Website
www.zoetis.com
Sector
Health Care
Industry
Pharmaceuticals
Data Updated:
Ready to invest in ZTS?

Commission-free trading available. Affiliate links.

ZTS Lician Score

10% confidence
5.0/10
Neutral

ZTS has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ZTSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ZTS Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

35810Value5.0Growth3.0Quality5.0Momentum5.0Safety5.04.6/10
5.0

Value

3.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for ZTS